OLIVIA BISIGNANO: Open Payments
NPI 1003419946 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 113 payments from 19 companies in 2025. Trend: 2023 $2,002 · 2024 $1,715 · 2025 $2,364
Food & beverage: $2,188Education: $176
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $480 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $279 |
| Incyte Corporation | 9 | $278 |
| ABBVIE INC. | 17 | $237 |
| Arcutis Biotherapeutics, Inc. | 26 | $184 |
| LEO Pharma Inc. | 9 | $148 |
| UCB, Inc. | 4 | $119 |
| REVANCE THERAPEUTICS, INC. | 1 | $115 |
| GENZYME CORPORATION | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
Products named: TREMFYA, OPZELURA, Zoryve, Winlevi, SKYRIZI, DUPIXENT, Bimzelx, DAXXIFY.
Industry payments across NV — which companies pay providers there.
